Clinical trials
Active, not recruiting Primary Myelofibrosis trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2021 | 3 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 8 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2 |
| Celgene | 1 |
| First Affiliated Hospital of Zhejiang University | 1 |
| Incyte Corporation | 1 |
| Karyopharm Therapeutics Inc | 1 |
| Novartis Pharmaceuticals | 1 |
| PharmaEssentia | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Primary Myelofibrosis | 8 |
| Myeloproliferative Disorders | 3 |
| Anemia | 1 |
| Bronchiolitis Obliterans Syndrome | 1 |
| Graft vs Host Disease | 1 |
| Leukemia, Myeloid, Acute | 1 |
| Myelodysplastic Syndromes | 1 |
| Polycythemia Vera | 1 |
| Recurrence | 1 |
| Thalassemia | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.